Morning Briefing
Summaries of health policy coverage from major news organizations
Pfizer To Expand Clinical Trials In Asia, Work On Development Of Antibiotics For Drug-Resistant TB
The pharmaceutical company Pfizer said on Wednesday that it plans to increase the number of clinical trials it's conducting in Singapore by 10 percent as part of an effort "to design drugs for diseases prevalent in the region," Reuters reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
